Phibro (PAHC) Insider Grant — 1,793 RSUs Awarded to VP Finance

Rhea-AI Filing Summary

Anthony Andolino, Vice President Finance and Treasurer of Phibro Animal Health Corp (PAHC), received an award of 1,793 restricted stock units (RSUs) on 08/15/2025. Each RSU represents a contingent right to one share of Class A common stock and was granted at a $0 price. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to continued employment through each vesting date. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Andolino on 08/19/2025.

Positive

• Officer received 1,793 RSU grant representing a contingent right to one Class A share each
• Vesting schedule spans three years, which supports retention and aligns executive incentives
• Timely SEC disclosure filed and signed by attorney-in-fact on 08/19/2025

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine officer equity grant aligns executive incentives; disclosure is standard and non-dilutive immediately.

The filing reports a standard grant of 1,793 RSUs to the company’s VP Finance and Treasurer. These RSUs are contingent rights to Class A shares and vest over three years in equal installments, which is a common retention and incentive structure. The grant price is reported as $0, indicating stock units rather than an option exercise. From a governance perspective, the disclosure is timely and conforms to Section 16 reporting requirements; there is no immediate share issuance or cash transaction disclosed that would materially change capital structure today.

Securities Analyst

TL;DR: Material impact to investors appears limited; this is an operational compensation disclosure, not a market-moving event.

The transaction involves 1,793 RSUs granted to an executive, vesting over three years. The report does not show any sale or exercise that would affect outstanding shares today. Absent information on total outstanding shares or aggregate insider holdings, this grant alone provides limited insight into dilution or ownership changes. The Form 4 fulfills disclosure rules but does not indicate a change in control, liquidity event, or other material corporate action.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Andolino Anthony

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NJ 07666

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	08/15/2025		A		1,793(2)	A	$0	1,793	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.

2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment through the applicable vesting date.

Remarks:

Vice President Finance and Treasurer. Exhibit List - Exhibit 24.1 Power of Attorney

	/s/ Judith Weinstein, as Attorney-in-Fact for Anthony Andolino	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PAHC insider Anthony Andolino report on Form 4?

He was granted 1,793 restricted stock units (RSUs) on 08/15/2025, each representing a right to one Class A share.

When do the RSUs granted to Anthony Andolino vest?

The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to continued employment.

Did the Form 4 show any securities sold by Anthony Andolino?

No; the filing reports an acquisition of RSUs and no disposition or sale of securities on the reported date.

What is the reported price for the RSU grant?

The transaction price is reported as $0, reflecting that these are restricted stock units rather than a cash purchase.

What is Anthony Andolino’s role at PAHC as stated in the filing?

He is Vice President Finance and Treasurer.